Remote & Hybrid Work

Teamsters at a NY cheese plant secured a new contract with higher wages and stronger job protections, reflecting a growing trend of union power in the U.S.

While tech giants cut jobs for AI, one firm is expanding in SF with a model that champions human connection. Here's why their hybrid approach is turning heads.

A new report reveals a major shift in cybersecurity strategy as firms abandon tool sprawl for unified control, driven by AI threats and cloud complexity.

AIROS Medical's FDA-cleared ARTAIRA device brings non-invasive PAD therapy home as global cases are projected to surge past 360 million by 2050.

With 46% of developers distrusting AI code, Qodo 2.0's new multi-agent architecture aims to restore faith by delivering more accurate, context-aware reviews.

As EQB prepares to release its Q1 2026 results, investors are watching to see if its digital strategy and PC Financial deal can fuel a rebound.

The tech platform is rapidly expanding, using private lots to solve a $100B industry problem and aiming for 10,000 locations by the end of 2026.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

Celebrating 100 quarters of growth and a new HQ, MDVIP's success highlights a major shift toward personalized, prevention-focused healthcare models.

A top KLAS award reveals a new era in healthcare cybersecurity, where measurable risk reduction and financial value are becoming more important than ever.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

A landmark survey reveals a massive capital rotation as 96% of institutions chase AI and 81% move to private markets to navigate a fragmenting world.

A new review calls Webroot a top VPN, but independent tests and affiliate marketing models tell a more complex story. Here's what you need to know.

Following promising early results, RESTEM's Restem-L cell therapy enters a pivotal Phase 2/3 trial, aiming to transform treatment for IIM patients.

With $10M in revenue and major institutional backing, Safe Project is proving that crypto infrastructure can be a sustainable business without token subsidies.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

New online communities offer an 'emotional prescription' for patients, but can the platform's 'gold standard' model balance support with business?

ezCater now lets employees order meals inside Slack, a move aimed at ending skipped lunches, reducing distractions, and boosting workplace productivity.

Ever.Ag's Feedlot IQ, an AI-powered platform, aims to revolutionize cattle management by unifying data for earlier health detection and improved efficiency.